Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...

More than 3,000 GPTs are reportedly in use at Moderna, which has partnered with OpenAI. Here's how they're using the technology.

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...

San Diego-based RNA biotech Arcturus is doubling down on mRNA therapeutics and stepping back from earlier-stage vaccine work ...

ANSWER: The problem isn’t that your immune system isn’t working; it’s working a little too well for your comfort but very ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

“We have vaccines against Covid, where we have pretty concrete ideas as to what works and what doesn’t work. We know they’re ...

Moderna researchers reported that the combo shot produced a stronger immune response against COVID-19 and most flu strains ...

A combination messenger RNA vaccine against COVID-19 and seasonal influenza stacked up well against currently recommended vaccines in a phase 3 trial, according to findings published in JAMA.

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business ...